[HTML][HTML] Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA …

G Boriani, L Gerra, DA Mei, M Vitolo, M Proietti… - European Journal of …, 2024 - Elsevier
Atrial fibrillation (AF) may be asymptomatic and the extensive monitoring capabilities of
cardiac implantable electronic devices (CIEDs) revealed asymptomatic atrial tachi …

Atrial cardiomyopathy: An entity of emerging interest in the clinical setting

G Boriani, L Gerra, M Mantovani, E Tartaglia… - European Journal of …, 2023 - Elsevier
Since 1995, the concept of atrial cardiomyopathy (ACM) has been associated with
myocardial fibrosis. Despite a consensus document in 2016, ACM's definition primarily relies …

Role of epicardial adipose tissue in cardiac remodeling

R Zou, M Zhang, W Lv, J Ren, X Fan - Diabetes Research and Clinical …, 2024 - Elsevier
Epicardial adipose tissue, or epicardial fat, is a type of visceral fat located between the heart
and the pericardium. Due to its anatomical proximity to the heart, EAT plays a significant role …

A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial …

G Boriani, E Tartaglia, JF Imberti - European journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke
prevention and cardiovascular outcomes in patients with atrial fibrillation A call to action: The need …

Systematic review and meta-analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing

DA Mei, JF Imberti, M Vitolo, N Bonini, K Serafini… - Europace, 2024 - academic.oup.com
Aims Physiological activation of the heart using algorithms to minimize right ventricular
pacing (RVPm) may be an effective strategy to reduce adverse events in patients requiring …

Assessment of Coronary Artery Disease in Non-Valvular Atrial Fibrillation: Is This Light at the End of the Tunnel?

A Batta, J Hatwal, YP Sharma - Vascular Health and Risk …, 2024 - Taylor & Francis
Non-valvular atrial fibrillation (NVAF) is the most common sustained arrhythmia worldwide,
and is associated with significant morbidity and mortality. Increasing life expectancy …

Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Assessment of an Old Problem

EP Zeitler, AE Johnson, LB Cooper, BA Steinberg… - Heart Failure, 2024 - jacc.org
Atrial fibrillation (AF) and heart failure (HF)—specifically, heart failure with reduced ejection
fraction (HFrEF)—often coexist, and each contributes to the propagation of the other. This …

Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis

P Karakasis, K Pamporis, KC Siontis… - European Heart …, 2024 - academic.oup.com
Abstract Background and Aims Current guidelines suggest that asymptomatic atrial
fibrillation (AF) is independently associated with increased risks of stroke and mortality …

Confused at a higher level, once more? Implications of asymptomatic vs. symptomatic, and clinical vs. subclinial atrial fibrillation

J Steffel - European Journal of Internal Medicine, 2024 - ejinme.com
About 20 years ago, the definition of atrial fibrillation (AF) seemed to be a very straight
forward one: An irregularly irregular heart rhythm, with no discernible P-waves and, ideally …